 |
 |

Persistent Lack of Detectable HIV-1 Antibody in a Person With HIV Infection—Utah, 1995
Arch Dermatol. 1996;132(8):873-874.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
 |  |
1. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994; 344:1333-4.
PUBMED
2. Pau CP, Hu DJ, Spurill C, et al. Surveillance for HIV-1 group O infections in the United States. Transfusion 1996 (in press). 3. Farzadegan H, Polis MA, Wolinsky SM, et al. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study. Ann Intern Med 1988;108:785-90.
FREE FULL TEXT
4. Roy MJ, Damato JJ, Burke DS. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 1993;269:2786-9.
5. Martin-Rico P, Pedersen C, Skinhoj P, Nielsen C, Lindhardt B. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man. AIDS 1995;9:95-6.
PUBMED
6. Soriano V, Dronda F, Gonzalex-Lopez A, Chaves F, Bravo R, Gutierrez M. HIV-1 causing AIDS and death in a seronegative individual. Vox Sang 1994; 67:410-1.
PUBMED
7. Food and Drug Administration. Revised recommendations for the prevention of human immunodeficiency virus transmission blood and blood products. Memorandum to all registered blood and plasma establishments. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1992. 8. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.
FREE FULL TEXT
9. Food and Drug Administration. Recommendations for donor screening with a licensed test for HIV-1 antigen. Memorandum to all registered blood and plasma establishments. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1995. 10. CDC. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR 1996;45(no. RR-2).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|